Meril – Nexgen – Çıplak Stent

Low Injury Design Philosophy

 

  • Unique hybrid cell design provides high radial strength & flexibility (65 µm struts)
  • Ultra high mirror finish
  • Low balloon overhang

Morphology Mediated Expansion

NEXGEN’s strut width variability results in a delightful expansion technique for

  • Superior conformability
  • Reduced edge injury

Excellent Scaffolding, No Recoil & Zero Foreshortening

  • 6, 8 & 10 crown configuration on variable diameters which allows for optimal scaffolding
  • S-links and Y-connectors ensure no recoil & zero foreshortening

Proof of Concept

Optimal Endothelialisation

  • Because of its superior conformability, 65µm thickness, NEXGEN is seen to endothelialise rapidly as
    amply demonstrated in porcine coronary artery model.

Currently not approved in U.S and Japan
NEXGEN is a registered trademark of Meril Life Science Pvt.Ltd.